TrialCancer immunology research2016

Phase I/II Study of Metastatic Melanoma Patients Treated with Nivolumab Who Had Progressed after Ipilimumab.

Jeffrey Weber et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.